NHS South of England Branded Medicines - Tranche A - September 2023
Details
- Buyer
- NHS England
- Supplier(s)
33 suppliers
- AVENTIS PHARMA LIMITED
- Abbvie Ltd
- Accord UK Ltd
- Almirall
- Amgen Ltd
- Astra Zeneca UK Limited
- Celltrion Healthcare United Kingdom Ltd
- Chugai Pharma UK Ltd
- Eli Lilly and Company Ltd
- Galapagos Biotech Ltd
- GEDEON RICHTER (UK) LIMITED
- GLAXOSMITHKLINE UK LIMITED
- Janssen Cilag Ltd
- Merck Serono Limited
- MERCK SHARP & DOHME (UK) LIMITED
- Merz
- Napp Pharmaceuticals Ltd
- Novartis Pharmaceutical UK Ltd
- Novo Nordisk Ltd
- Organon Pharmaceuticals UK Ltd
- Orifarm UK
- Pfizer Liimted
- Pharmacosmos UK Ltd
- Ranbaxy (UK) Ltd
- Roche Products Ltd
- Sandoz
- Swedish Orphan Biovitrum Ltd (Sobi UK Ltd)
- Takeda UK Limited
- Teva UK Ltd
- Thornton and Ross
- UCB Pharma Ltd
- Vifor Pharma UK Ltd
- Zentiva Pharma UK Ltd
- Value
- GBP 249,832,000
- Duration
- 2 years
- Topic
- Pharmaceutical products
- Published
- 14 August 2023
- Source
- uk:contracts_finder
Tender description
NHS South of England Branded Medicines - Tranche A - September 2023 Offer reference number: CM/PHR/22/5676 CM/PHR/22/5676/01 - NHS Framework for South of England Branded Medicines - Tranche A. Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5676/02 - NHS Framework for South of England Branded Medicines - Annual Tranche. Period of framework: 1 September 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months. CM/PHR/22/5676/03 - NHS Framework Agreement for the supply of Risankizumab for the Midlands & East and North of England. Period of framework: 1 September 2023 to 29 February 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months.
Timeline
- Completed: Award published14 August 2023Current notice
- Completed: Award date1 September 2023
- Completed: Contract expiry date31 August 2025
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS South of England Branded Medicines - Tranche A - September 2023.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 455£2.1bn
- 367£249.3m
- 353£15.0bn
- 293£2.8bn
- 261£19.7bn
- 252£892.4m
- 243£509.0m
- 203£1.0bn
- 140£895.5m
- 114£59.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
